Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.
We'd appreciate your feedback.Tell us what you think! opens in new tab/window
Find us at booth #732.
Here you can find curated content to inform you about Elsevier’s solutions for supporting industry goals in AI and R&D.
SOT Talks:
[Room (Day X): Date, Time, “talk title,” Olivier Barberan, Job Title
[Room (Day X): Date, Time, “talk title,” Olivier Barberan, Job Title
[Room (Day X): Date, Time, “talk title,” Olivier Barberan, Job Title
Email us any questions here opens in new tab/window.
Used by the FDA and the world’s top pharma companies PharmaPendium provides manually extracted and full-text searchable FDA and EMA approval packages, enabling researchers to:
predict the success of drug candidates
reduce animal testing
anticipate post-market safety risks
optimizing clinical trial design,
check for drug-drug interactions
reduce the risk of off-target-related adverse events
A gold standard solution for biomedical literature and conference abstracts. It is designed to support literature research for drug and device development, including:
systematic reviews
safety monitoring
adverse event screening
repositioning
A 2024 CODiE finalist, Embiology visualizes millions of biological relationships and pathways to:
understand disease biology
support target identification and prioritization
We license high-quality and machine-readable datasets for a range of use cases:
